A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Clinical trial NCT07355855 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07355855
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.